Pentacyclic triterpenoids from Mitracarpus frigidus (Willd. ex Roem. & Schult.) K. Shum: in vitro cytotoxic and leishmanicidal and in vivo anti-inflammatory and antioxidative activities

被引:0
作者
Rodrigo Luiz Fabri
Roberta Alvim Garcia
Jônatas Rodrigues Florêncio
Lidiane Oliveira de Carvalho
Nícolas de Castro Campos Pinto
Elaine Soares Coimbra
Elaine Maria de Souza-Fagundes
Antônia Ribeiro
Elita Scio
机构
[1] Federal University of Juiz de Fora,Bioactive Natural Products Laboratory, Department of Biochemistry, Biological Sciences Institute
[2] Federal University of Juiz de Fora,Department of Parasitology, Microbiology and Immunology, Institute of Biological Sciences
[3] Federal University of Minas Gerais,Department of Physiology and Biophysics, Biological Sciences Institute
来源
Medicinal Chemistry Research | 2014年 / 23卷
关键词
Pentacyclic triterpenoids; Ursolic acid; Methyl ursolate; Anti-inflammatory activity; Antileishmanial activity;
D O I
暂无
中图分类号
学科分类号
摘要
Previous studies had shown that different extracts obtained from Mitracarpus frigidus (Willd. ex Roem. & Schult.) K. Shum, an annual shrub commonly found in South America, present antimicrobial, leishmanicidal, cytotoxic, laxative, and anti-inflammatory activities. Thus, this study aimed to isolate the bioactive compounds from the hexane extract of the aerial parts of this plant and to evaluate some of their biological activities. The bioactivity guided fractionation of the hexane extract of M. frigidus afforded two pentacyclic triterpenoids, ursolic acid and methyl ursolate. Their identities were confirmed unambiguously by way of 1H, 13C, 1H COSY, HMBC, HMQC, Dept 135, IR and UV–Vis spectroscopy, and mass spectrometry. These compounds, hitherto unknown in the species, were evaluated for their in vitro biological activities against four tumor cell lines (HL60, Jurkat, MCF-7, and HCT) and four Leishmania species (L. amazonensis, L. major, L. braziliensis, and L. chagasi). Also, their in vivo anti-inflammatory effect was evaluated using carrageenan-induced paw edema and carrageenan-induced peritonitis. Ursolic acid was active for all tumor cell lines with ED50 values varying from 4.2 to 35.7 μg/mL, and methyl ursolate was active only for HL60 cells with an ED50 value of 22.7 μg/mL. A pronounced antileishmanial potential was verified for amastigote form of L. major, with IC50 values of 1.3 and 2.1 μg/mL for ursolic acid and methyl ursolate, respectively. They also presented in vivo anti-inflammatory effects in the carrageenan-induced paw edema test. Oral administration of these triterpenoids at 1 mg/kg significantly inhibited edema formation induced by carrageenan by 80 % and peritoneal leukocyte migration by 85 %. The results obtained reinforced that pentacyclic triterpenoids are an important class of natural products for investigation in the search of new bioactive compounds.
引用
收藏
页码:5294 / 5304
页数:10
相关论文
共 200 条
[21]  
Matos MO(2005) antileishmanial, antiplasmodial and cytotoxic activities of phenolics and triterpenoids from J Pharm Biomed Anal 36 3463-3470
[22]  
Brandão HN(1987) D.C. (Asteraceae) Biochem Pharmacol 27 1-93
[23]  
David JP(2006)Comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse Mol Aspects Med 566 215-221
[24]  
Couto RD(2007)Chemical studies of Eur J Pharmacol 98 5821-5826
[25]  
Nascimento JAP(2000) (Sw.) DC—a medicinal rubiaceous weed Proc Natl Acad Sci USA 39 1483-1484
[26]  
David JM(1995)Effects of ursolic acid and its analogues on soybean 15-lipoxygenase activity and the proliferation rate of a human gastric tumour cell line Phytochemistry 21 3485-3491
[27]  
Carmo AML(2001) aerial parts exhibited potent antimicrobial, antileishmanial, and antioxidant effects Anticancer Res 65 4799-4808
[28]  
Silva FMC(2005) laxative and toxicological evaluation and in vitro antitumor effects of Cancer Res 52 26-42
[29]  
Machado PA(2008) aerial parts Mol Nutr Food Res 118 527-529
[30]  
Carvalho GSG(2008)Anti-inflammatory and antioxidative effects of the methanolic extract of the aerial parts of J Ethnopharmacol 6 2868-2885